CD8A and neoplasm: The DAMPs, IL-1β and IL-18 released by pyroptosis of tumor cells can also effectively initiate CD8+ T cell expansion and promote NK cell recruitment, activate a tumor immune response, and improve the efficacy of immunotherapy52–54.